Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: Emergent BioSolutions Inc (EBS)

Tandha merek Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions (EBS) profitability is based on the efficient allocation of government contracts and the duplication of capacities. The gross operating profit before depreciation trend on the GURU.Markets chart shows that the current value is 122.00. However, debt load and dependence on government procurement create financial risks, although the humanitarian status of the products ensures stability amidst global geopolitical tension.

EBS Emergent BioSolutions: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 10.11.2026

Ringkesan rincian data analitis Emergent BioSolutions Inc. (EBS)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Emergent BioSolutions
Produk asil prodhuksi Emergent Corp

For Emergent BioSolutions (EBS), operating profit reflects the efficiency of its crisis transformation and the divestment of non-core assets, measuring cash flow from core operations before depreciation and interest. Analyzing the EBITDA history allows for an assessment of the revamped management's actual ability to stabilize liquidity, turning this indicator into the primary criterion for evaluating the fair value of capital and the risks of overpayment.